Leica Biosystems is a global leader in laboratory workflow solutions for anatomic pathology, striving to advance cancer diagnostics to improve patients’ lives. Leica Biosystems provides a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. Recognizing there is a shortage of pathology expertise worldwide, as well as increasing subspecialization, Leica Biosystems expanded its capability in pathology imaging with Aperio ePathology Solutions enabling greater access for pathologists through market leading whole slide scanners, Network solutions that enables remote, real-time viewing and easy distribution of images for collaboration and Precision solutions that provide pathologists with easy-to-use quantitative image analysis to improve clinical and research productivity, reproducibility and consistency.
In March, Leica Biosystems, announced that Chinese physicians now have access to U.S. healthcare organizations for real-time, expert review of pathology cases through the first scalable, secure medical cloud network with its strategic collaboration with Dell Healthcare and Life Sciences. The U.S. institutions providing pathology services include: The Johns Hopkins Hospital, Cleveland Clinic, Hospital of the University of Pennsylvania, Dianon/Lab Corp. and ProPath. The cloud-based solution, powered by Dell’s Unified Clinical Archive, is a global, secure and scalable IT platform. This provides the foundation of best practices to optimize access to large pathology images so physicians can quickly and easily review and collaborate to expedite patient results and treatment decisions.